Alfa Chemistry Announces the Launch of Innovative IVD Products for Laboratory Use

Optibrium introduces cloud-based version of StarDrop drug discovery platform

Optibrium introduces a cloud-based version of StarDrop, its drug discovery platform.

Creative Enzymes Unveils the Creative SuperCut Series: Redefining Precision in Molecular Biology

Creative Enzymes Unveils Advanced Substrate, Inhibitor, and Ligand Screening Services

Creative Biolabs Unveils ADC Services, Igniting Excitement in the Biotech Industry

Creative Biolabs, a prominent provider of groundbreaking biotechnology solutions, proudly announced the expansion of its antibody-drug conjugate (ADC) business with the introduction of novel services.

Empowering Research Excellence: Alfa Chemistry's THEIC, D-Pantethine, and Methoxytriethyleneoxypropyltrimethoxysilane at the Forefront

Andelyn Biosciences and Purespring Therapeutics Partner to Manufacture Novel Gene Therapies for Kidney Diseases

Andelyn Biosciences and Purespring Therapeutics Partner to Manufacture Novel Gene Therapies for Kidney Diseases Andelyn Biosciences, Inc., a pioneering and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has partnered with Purespring Therapeutics, a biotech innovator company, to accelerate the manufacture of their gene therapies for the treatment of chronic renal diseases that are currently poorly addressed.

Magritek opens up benchtop NMR to new reaction monitoring applications

CD Formulation's Scientists Share A Holistic Approach on How to Prepare Drug Microcapsules

Cresset Targets International Growth with Innovate UK Scaleup Programme

Drug discovery specialists Cresset have joined Innovate UK’s Scaleup Programme for businesses with high growth potential

New £30m Initiative to Address Global Threat by Accelerating the Pace of Antimicrobial Innovation

Pioneering partnership to drive development of new tests and treatments to tackle deadly antimicrobial resistance, which could otherwise kill 10 million a year by 2050

CD Genomics Revolutionizes TCR-Seq Elevating Immune Repertoire Profiling to New Heights

CD Genomics Unveils Cutting-Edge CRISPR Screen Sequencing Technology

BOC Sciences at TIDES Europe 2023: Key Chemicals and XDC Platform to Be Exhibited

BOC Sciences will attend "TIDES Europe: Oligonucleotide & Peptide Therapeutics", delivered as a hybrid event from 30 Oct - 1 Nov 2023, in Amsterdam, NL. Its high-yield nucleosides & nucleotides, as well as a newly launched XDC platform, will be exhibited in front of the industry.

CD Genomics Introduces Cutting-Edge Degradome Sequencing Service Redefining Transcriptomics Research

Biotium Introduces New Highly-Selective Stains For Both Gram-Positive and Gram-Negative Bacteria

Biotium has announced the launch of its breakthrough BactoView™ Dead Stains and BactoView™ Viability Kits.

LIXTE, Netherlands Cancer Institute, and Oncode Institute to Expand Collaboration

LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT and LIXTW) has signed an agreement to expand its collaboration with the Netherlands Cancer Institute (NKI) and Oncode Institute to study drug synergies of LIXTE’s lead clinical compound, LB-100, with immunotherapy in various cancers. The new agreement also will seek to find synthetic lethal combinations in additional cancer types.

Inizio Engage launches new global powerhouse learning brand, Nazaré

Censinet and First Health Advisory Partner to Deliver Comprehensive Cyber Risk Assurance to Health Sector

Partnership Enables Healthcare Organizations to Leverage Unique Risk Advisory Services and Purpose-Built Workflow Automation to Maximize Cyber Risk Reduction

JPA HEALTH EXPANDS LIFE SCIENCES DIVISION WITH ACQUISITION OF TRUE NORTH SOLUTIONS, INC.

Addition brings together synchronized experts to offer comprehensive predictive analytics, data visualization and AI-driven end-to-end solutions for life sciences, government and non-profit organizations